Syndrome of inappropriate secretion of antidiuretic hormone

E4_ANTIDIU

inappropriate ADH syndrome: A syndrome characterized by abnormal secretion of antidiuretic hormone in conjunction with neoplastic growth occurring anywhere in the body.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E22.2
  • Hospital discharge: ICD-9 2536X
  • Cause of death: ICD-10 E22.2
  • Cause of death: ICD-9 2536X

2 out of 7 registries used, show all original rules.

157

4. Check minimum number of events

None

157

5. Include endpoints

None

157

6. Filter based on genotype QC (FinnGen only)

149

Control definitions (FinnGen only)

Control exclude E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E22
Name in latin Syndroma secretionis impropriae hormonis antidiuretici

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1631 971 648
Only index persons 1405 854 551
Unadjusted period prevalence (%)
Whole population 0.02 0.03 0.02
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 71.56 74.37 67.48
Only index persons 72.04 74.92 67.57

-FinnGen-

Key figures

All Female Male
Number of individuals 149 76 73
Unadjusted period prevalence (%) 0.03 0.03 0.04
Median age at first event (years) 69.24 69.42 69.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

Mortality – FinRegistry

Association

Association between endpoint E4_ANTIDIU and mortality.

Females

Parameter HR [95% CI] p-value
E4_ANTIDIU 2.117 [1.65, 2.72] < 0.001
Birth year 0.994 [0.98, 1.0] 0.177

During the follow-up period (1.1.1998 — 31.12.2019), 348 out of 767 females with E4_ANTIDIU died.

Males

Parameter HR [95% CI] p-value
E4_ANTIDIU 3.366 [2.32, 4.88] < 0.001
Birth year 0.984 [0.97, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 270 out of 507 males with E4_ANTIDIU died.

Mortality risk

Mortality risk for people of age

years, who have E4_ANTIDIU.

N-year risk Females Males
1 0.198% 0.597%
5 1.064% 3.778%
10 2.882% 8.794%
15 5.999% 16.438%
20 10.228% 26.295%

Relationships between endpoints

Index endpoint: E4_ANTIDIU – Syndrome of inappropriate secretion of antidiuretic hormone

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data